Evidence map›Paper›PMID 20017120›Full record

ReviewBiomedical chromatography : BMC2010

Analysis of endogenous glutathione-adducts and their metabolites.

Ian A Blair

Abstract readReview
In one paragraph

Review in Biomedical chromatography : BMC, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Peripheral S-(PGJBMC psychiatry · 2026
    Article
  2. Identification and Quantitation ofMethods and protocols · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in pharmacology · 2022
    Article
  7. Discovery of New Chemical Tools againstPharmaceuticals (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Glutathione efflux and cell death.Antioxidants & redox signaling · 2012
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ian A BlairCenters of Excellence in Environmental Toxicology and Cancer Pharmacology, Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-4863, USA. ianblair@mail.med.upenn.edu

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca A Simmons · 2006 to 2026
$35.3M
Molecular Dosimetry of Endogenous GenotoxinsR01CA091016 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BLAIR, IAN ALEXANDER · 2001 to 2010
$2.6M
Exposure and biological response biomarkers of cigarette smokeU01ES016004 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI BLAIR, IAN ALEXANDER · 2007 to 2010
$2.5M
Molecular mechanisms of DNA damage by PAHsR01CA130038 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BLAIR, IAN ALEXANDER · 2007 to 2011
$1.8M
NCI NIH HHS R01 CA091016NCI NIH HHS R01CA091016NCI NIH HHS R01 CA130038NIEHS NIH HHS P30ES0130508NIEHS NIH HHS P30 ES013508NIEHS NIH HHS U01 ES016004NIEHS NIH HHS UO1ES16004PHS HHS R00130038
6 · The paper itself

Abstract

The ability to conduct validated analyses of glutathione (GSH)-adducts and their metabolites is critically important in order to establish whether they play a role in cellular biochemical or pathophysiological processes. The use of stable isotope dilution (SID) methodology in combination with liquid chromatography-tandem mass spectrometry (LC-MS/MS) provides the highest bioanalytical specificity possible for such analyses. Quantitative studies normally require the high sensitivity that can be obtained by the use of multiple reaction monitoring (MRM)/MS rather than the much less sensitive but more specific full scanning methodology. The method employs a parent ion corresponding to the intact molecule together with a prominent product ion that obtained by collision induced dissociation. Using SID LC-MRM/MS, analytes must have the same relative LC retention time to the heavy isotope internal standard established during the validation procedure, the correct parent ion and the correct product ion. This level of specificity cannot be attained with any other bioanalytical technique employed for biomarker analysis. This review will describe the application of SID LC-MR/MS methodology for the analysis of GSH-adducts and their metabolites. It will also discuss potential future directions for the use of this methodology for rigorous determination of their utility as disease and exposure biomarkers.

Indexed as

AnimalsChromatography, LiquidGlutathioneHumansTandem Mass SpectrometryGlutathione

Identifiers

PMID20017120
PMCPMC3802536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.